ROME Therapeutics

ROME Therapeutics is harnessing the power of repetitive genomes to develop new therapies for cancer and autoimmune diseases, with large amounts of unknown genetic material long regarded as "junk DNA." Having identified several drug targets and implementing multiple discovery programs, ROME is moving quickly to capitalize on this new field of biology. To lead this exploration, ROME has assembled a team of world-class leaders, bringing together leading experts in oncology, immunology, machine learning, virology, and even theoretical physics.